Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Aviir's Cardiovascular Panels; Natera's Panorama; WaferGen's SmartChip TE

Premium

Aviir has launched two comprehensive genetic panels to test for undiagnosed arrhythmia or cardiomyopathy. The tests cover the major causes of cardiomyopathies, arrhythmia disorders, and other genetically transmitted diseases that affect the heart and vasculature. Each test is available for testing in both individual and familial settings.


Natera will now offer Panorma, its noninvasive sequencing-based test to screen for fetal aneuploidies, in Spain. The company is distributing the test through Echevarne, a clinical analysis laboratory in Spain. Natera first launched its test in the US in March.


WaferGen has launched SmartChip TE, a PCR-based target enrichment solution for sample preparation prior to targeted re-sequencing. The company said that the kit will be especially useful for clinical applications because it is based on proprietary technology that relies on massively parallel single-plex PCR reactions, where amplification is cleaner and better controlled, which will provide more accurate sequencing results.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.